Skip to content
Clinical Trials – home

Haemodialysis Treatment

7 / 9 trials open to patients5 countries

In short

Hemodialysis is a life-supporting treatment that filters waste products and excess fluids from the blood when kidneys can no longer perform this essential task. For people facing kidney failure, this procedure can help maintain health and improve quality of life, though it requires significant lifestyle adjustments and regular medical care.

Key points

  • Hemodialysis is a life-sustaining treatment that performs the filtering job of failed kidneys, removing waste products and excess fluids from blood through an artificial kidney machine called a dialyzer.
  • About 90% of dialysis patients receive hemodialysis, making it the most common form of kidney replacement therapy, with approximately 2.5 million people worldwide depending on it.
  • Standard in-center treatment involves three sessions per week lasting three to four hours each, though home hemodialysis options offer more flexibility with daily or overnight schedules.
  • A dialyzer contains thousands of tiny hollow fibers that filter blood while dialysate solution flows in the opposite direction, pulling waste products out of the bloodstream.
  • Patients need surgical creation of vascular access in the arm weeks or months before starting dialysis to allow blood to flow rapidly in and out of the body during treatment.
  • Success with hemodialysis requires following a strict treatment schedule, taking multiple medications at specific times, and adhering to dietary restrictions on potassium, phosphorus, sodium, and fluids.
  • Home hemodialysis requires weeks to months of training but offers potential benefits including better blood pressure control, fewer symptoms, and greater scheduling freedom for those who can manage the responsibility.
  • Missing dialysis sessions is dangerous because waste products and fluids build up to toxic levels, potentially causing life-threatening complications within days.

When Kidneys Need Help: Understanding Treatment Goals

When kidneys lose their ability to clean the blood properly, the body faces a serious problem. Waste products, extra salt, and fluids begin to accumulate, creating dangerous conditions that can threaten life itself. Hemodialysis steps in to perform the job that failing kidneys can no longer handle. The treatment aims to remove toxic substances from the bloodstream, control blood pressure, and maintain proper levels of important minerals like potassium, sodium, and calcium.

The decision to start hemodialysis depends on several factors that doctors carefully evaluate. These include how much kidney function remains, the presence of symptoms like nausea or swelling, overall health status, and individual patient circumstances. Medical professionals use a measurement called estimated glomerular filtration rate (eGFR) to assess kidney function. This number tells doctors what percentage of normal kidney activity remains. Generally, hemodialysis becomes necessary when kidney function drops to only 10-15% of normal capacity.

It's important to understand that hemodialysis is not a cure for kidney failure. Rather, it's a treatment that helps people feel better and live longer by taking over critical kidney functions. Some people need it temporarily while their kidneys recover from sudden injury. Others, particularly those with end-stage kidney disease (ESKD), will require it for the rest of their lives unless they receive a kidney transplant.

The treatment has become increasingly sophisticated over decades of medical advancement. Today, approximately 90% of people who need dialysis receive hemodialysis, making it the most common form of renal replacement therapy worldwide. Around 2.5 million people globally depend on this treatment to stay alive.

Standard Hemodialysis Treatment: How It Works

During a hemodialysis session, blood is removed from the body through a specially created access point, typically in the arm. The blood travels through soft tubes into a machine containing an artificial kidney called a dialyzer. Inside this device, blood flows through thousands of very thin, hollow fibers. On the other side of these fibers, a special cleaning solution called dialysate moves in the opposite direction. As blood passes through the fibers, waste products and excess fluid move across the fiber walls into the dialysate solution. The cleaned blood then returns to the body through another tube.

The dialysate is carefully formulated with water and specific chemicals designed to safely draw out wastes and toxins. A kidney specialist, called a nephrologist, prescribes the exact composition of this solution based on each patient's individual needs. The dialysis machine continuously monitors blood pressure and controls how quickly blood flows through the system and how much fluid is removed from the body.

Before hemodialysis can begin, patients need a surgical procedure to create vascular access. This is a crucial step because dialysis requires blood to flow out of and back into the body rapidly and repeatedly. Surgeons enlarge blood vessels—usually an artery and vein in the arm—to make this possible. At the start of each treatment session, a dialysis nurse or technician places two needles into this access site. Some patients learn to place the needles themselves after receiving proper training. Numbing cream or spray can be used if needle placement causes discomfort.

In-Center Treatment

Most people receive hemodialysis at specialized dialysis centers. This is called in-center hemodialysis, and it follows a standard schedule that typically involves three sessions per week. Each session lasts approximately three to four hours, though some larger patients may need treatments lasting up to five hours. The entire process is managed by trained healthcare providers, including dialysis nurses and technicians who specialize in this type of care.

At a treatment center, medical staff handles all technical aspects of the procedure. However, patients still carry important responsibilities. They must keep scheduled appointments consistently, follow dietary restrictions carefully, and take prescribed medications as directed. Many people feel tired for several hours after each session, which is a normal response to the treatment.

Home Hemodialysis Options

An alternative to center-based treatment is home hemodialysis, which allows patients to perform the procedure in their own homes. This option isn't suitable for everyone, but it offers several advantages for those who can manage it. Medicare and most health insurance plans cover the costs of home dialysis equipment and supplies, just as they would for in-center treatment.

Home hemodialysis requires extensive training that can take several weeks to months. Patients must learn to handle the equipment, place needles correctly, monitor the machine and their blood pressure during treatment, keep detailed records, clean the machine properly, and order necessary supplies. A family member or caregiver can also be trained to help with the process. Dialysis nurses provide this comprehensive education to ensure patients feel confident and capable.

There are three main types of home hemodialysis schedules. Conventional home hemodialysis follows the standard pattern of three sessions per week, each lasting three to four hours. Short daily home hemodialysis uses newer technology that allows for shorter, two-hour sessions performed five to seven days per week. Nocturnal hemodialysis takes place at night while the patient sleeps, with sessions lasting six to eight hours and occurring four to six nights per week.

More frequent or longer home treatments offer potential benefits. Because dialysis happens more often or for extended periods, waste removal becomes more thorough. Many patients experience better blood pressure control and may need fewer blood pressure medications. The treatment tends to be gentler on the heart and can cause fewer side effects like nausea, headaches, muscle cramps, itching, and fatigue. Additionally, home treatment offers greater flexibility in scheduling, allowing patients to fit dialysis around work, family, and personal activities.

Medication and Dietary Requirements

People on hemodialysis typically take multiple medications as part of their treatment plan. The timing of these medications matters significantly. For instance, phosphate binders must be taken with meals to prevent the body from absorbing too much phosphorus from food. A special renal vitamin is usually prescribed to be taken at night or after dialysis sessions. Patients should maintain a complete list of all medications, including over-the-counter products and supplements, and discuss them with their healthcare team.

The dialysis diet differs substantially from typical eating patterns. While there are foods and beverages to avoid or limit, the diet should be viewed as a way to take control of health rather than a series of restrictions. Key considerations include limiting potassium, phosphorus, sodium, and fluids. The amount of protein needed changes once dialysis begins—patients often need more protein than before. A specialized kidney dietitian can provide personalized guidance and help patients discover new, kidney-friendly recipes and meal ideas.

Possible Complications and Side Effects

Like any medical treatment, hemodialysis can cause complications. Understanding these potential problems helps patients recognize warning signs and seek help promptly. Common issues during or after treatment include low blood pressure, muscle cramps, nausea, vomiting, headaches, and fatigue. These symptoms often improve as patients adjust to treatment, though they should always be reported to the healthcare team.

Problems can develop with the vascular access site. Patients should watch for signs of infection such as redness, swelling, soreness, pain, warmth, or pus around the access area. Bleeding from the access site or feeling that the arm is cold, numb, or weak requires immediate medical attention. If the hand on the side where the catheter is placed becomes cold or swollen, this signals a potential circulation problem that needs urgent evaluation.

Some people experience fluid shifts during dialysis, which means fluid moves between different body compartments as excess water is removed. This can contribute to low blood pressure or dizziness during treatment. The dialysis team adjusts the treatment parameters to minimize these effects. Taking prescribed medications consistently, following fluid restrictions, and maintaining the dialysis schedule all help reduce complications.

Long-term complications can include issues with mineral balance. Over time, some patients develop problems with bones and joints due to imbalances in calcium, phosphorus, and parathyroid hormone levels. Regular blood tests help monitor these minerals, and medications can help keep them in a healthy range. Additionally, patients on long-term dialysis may experience anemia (low red blood cell count), which can be treated with medications that stimulate red blood cell production.

Research and Innovations in Dialysis Treatment

The field of hemodialysis continues to evolve as researchers work to improve treatment outcomes and quality of life for patients. Clinical studies are exploring various aspects of dialysis care, from new technologies to different treatment schedules. While these investigations show promise, they are in various stages of research and not yet standard practice.

One area of active research involves refining dialysis schedules. Some studies are examining whether more frequent but shorter treatments or longer overnight sessions provide better outcomes than the traditional three-times-weekly schedule. Early findings suggest that more frequent dialysis may offer benefits including better blood pressure control, reduced medication needs, and fewer symptoms like fatigue and nausea. However, researchers continue to study which patients benefit most from these approaches and how to make them practical and accessible.

Innovations in dialysis technology focus on making machines more efficient, portable, and user-friendly. Researchers are developing smaller, more automated devices that could make home dialysis easier and more appealing. Some experimental machines can perform shorter treatments more frequently, potentially offering better waste removal while reducing the time burden on patients. These technologies are being tested to ensure they are safe and effective before becoming widely available.

Scientists are also investigating ways to improve dialyzer membranes—the filters inside the artificial kidney. Different membrane materials and designs affect how efficiently waste products are removed and whether beneficial substances are preserved. Research into high-flux dialyzers, which have larger pores allowing removal of medium-sized waste molecules, suggests they may reduce certain long-term complications. Studies continue to evaluate which membrane types work best for different patient populations.

Another research direction examines the composition of dialysate solutions. Standard dialysate contains specific levels of electrolytes and minerals, but some patients might benefit from customized formulations. Clinical trials are testing whether adjusting bicarbonate levels, sodium concentrations, or other dialysate components can improve how patients feel during and after treatment or reduce long-term complications.

Investigators are studying the concept of incremental hemodialysis, where patients with some remaining kidney function start with fewer or shorter dialysis sessions and gradually increase treatment as kidney function declines. This approach recognizes that patients maintaining residual kidney function might not need full-intensity dialysis immediately. Research suggests this strategy could preserve remaining kidney function longer, reduce treatment burden initially, and improve quality of life, though more studies are needed to establish clear guidelines.

Efforts to improve vascular access continue as well. Researchers are exploring new surgical techniques, materials, and monitoring methods to help access sites last longer and develop fewer complications. Some studies examine medications or treatments that might prevent access problems before they occur.

While these research areas show potential, it's important to emphasize that most are still being investigated in clinical trials. Patients interested in newer approaches should discuss them with their nephrologist, who can explain whether these options are available, appropriate, and safe based on individual circumstances. The standard hemodialysis approaches described earlier remain the proven, established methods of treatment.

Most common treatment methods

  • In-center hemodialysis
    • Performed at specialized dialysis centers three times per week
    • Each session lasts three to four hours
    • Healthcare professionals manage all technical aspects of treatment
    • Blood is removed from the body, filtered through a dialyzer machine, and returned cleaned
    • Most common form of dialysis, used by approximately 90% of dialysis patients
  • Home hemodialysis
    • Conventional home hemodialysis performed three times weekly for three to four hours per session
    • Short daily home hemodialysis done five to seven days per week for about two hours per session
    • Nocturnal home hemodialysis performed four to six nights per week for six to eight hours while sleeping
    • Requires extensive training of patient or caregiver over several weeks to months
    • Offers more flexibility in scheduling and may provide better blood pressure control and fewer symptoms
  • Vascular access creation
    • Surgical procedure to create access point for dialysis, typically in the arm
    • Involves enlarging blood vessels to allow rapid blood flow for dialysis
    • Must be created weeks or months before starting hemodialysis
    • Two needles are inserted into access site at each treatment session
    • Requires careful monitoring for signs of infection or other complications
  • Medication management
    • Phosphate binders taken with meals to control phosphorus levels
    • Renal vitamins prescribed to replace vitamins lost during dialysis
    • Blood pressure medications adjusted based on dialysis schedule and fluid status
    • Medications to treat anemia by stimulating red blood cell production
    • Careful timing of medications required—some must be taken with food, others after dialysis
  • Dietary modifications
    • Kidney-friendly diet limiting potassium, phosphorus, sodium, and fluids
    • Increased protein intake often needed once dialysis begins
    • Working with specialized kidney dietitian to create personalized meal plans
    • Monitoring of mineral levels through regular blood tests
    • Following fluid restrictions to prevent excess fluid buildup between treatments

Did you know?

  1. The dialyzer used in hemodialysis contains approximately 10,000 to 15,000 tiny hollow fibers through which your blood flows, creating a massive surface area for waste removal—similar to having thousands of miniature kidneys working simultaneously.
  2. The term "dialysis" comes from ancient Greek words meaning "through" and "loosening"—referring to how the treatment loosens and separates waste products from blood through a membrane, a principle understood since ancient times though only successfully applied to kidney treatment in the 20th century.
  3. Approximately 2.5 million people worldwide depend on dialysis to stay alive, yet this represents only a fraction of those who need it—in many countries, dialysis remains inaccessible due to cost or lack of facilities, making kidney failure a fatal condition for millions who cannot access treatment.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Haemodialysis

Recruiting trials first

See all 9 trials →
Quick filters

9 clinical trials in this condition

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Hospices Civils De Lyon

Haemodialysis

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Rivaroxaban
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Warfarin Sodium
  • Sponsor:Rigshospitalet

Cardiovascular disorder+3

Not yet recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Karolinska University Hospital

Haemodialysis

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Keto-Leucine Calcium

Haemodialysis

Not yet recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Alanine
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See all 9 trials →filters applied: condition = Haemodialysis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).